ENTPD1 and breast neoplasm: Besides the up-regulated expression of CD39 and PD-1, the expanded CD4+ T cells within the breast tumor tissue showed greater levels of CD25, signifying that although they are activated but exhausted and incapable of mounting any tumor-specific immune response [31].